IXO Private Equity
Description
IXO Private Equity is a prominent independent private equity firm based in the South of France, with offices in Toulouse and Marseille. The firm specializes in providing growth capital, facilitating leveraged buyouts (LBOs), and supporting management buy-ins/buy-outs (MBI/MBOs) for small and medium-sized enterprises (SMEs) and mid-caps (ETIs). Their investment philosophy is rooted in partnering with experienced management teams to unlock value and accelerate development in both mature and growing sectors, contributing significantly to regional economic dynamism.
The firm's investment strategy targets companies with strong growth potential, often those with revenues ranging from €10 million to €200 million. IXO Private Equity maintains a diversified portfolio, with investments spanning various key sectors including healthcare, services, industry, and technology. They are particularly adept at identifying robust businesses within these sectors that can benefit from strategic guidance and financial backing to achieve their next phase of growth, whether through organic expansion, internationalization, or strategic acquisitions.
IXO Private Equity manages a comprehensive suite of funds, including FCPR (Fonds Communs de Placement à Risque) and FIP (Fonds d'Investissement de Proximité) structures, and also advises IRDI Capital Investissement, an evergreen fund, showcasing their versatile funding mechanisms. A significant milestone was the successful closing of their IXO PME 2 fund at €200 million in 2021, demonstrating strong investor confidence and market recognition. Overall, the firm boasts over €850 million in assets under management, underscoring its substantial footprint in the French private equity landscape. With a track record of over 200 transactions since its inception, IXO Private Equity plays a crucial role in fostering economic development and job creation by empowering local businesses.
Investor Profile
IXO Private Equity has backed more than 62 startups, with 1 new investments in the last 12 months alone. The firm has led 15 rounds, about 24% of its total and boasts 11 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Private Equity, Series Unknown, Series A rounds (top funding stages).
- Majority of deals are located in France, United States, The Netherlands.
- Strong thematic focus on Health Care, Manufacturing, Biotechnology.
- Typical check size: $1M – $22M.
Stage Focus
- Private Equity (40%)
- Series Unknown (24%)
- Series A (13%)
- Series B (11%)
- Series C (5%)
- Seed (3%)
- Series E (2%)
- Debt Financing (2%)
Country Focus
- France (90%)
- United States (5%)
- The Netherlands (3%)
- Canada (2%)
Industry Focus
- Health Care
- Manufacturing
- Biotechnology
- Software
- Medical
- Medical Device
- Therapeutics
- Information Technology
- Internet Of Things
- Artificial Intelligence (Ai)
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
